Mylotarg Must Go

Monday, June 28, 2010 - 11:28 in Health & Medicine

The only antibody-drug conjugate on the market has efficacy and safety issues.

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net